Depigmentation

From Wikipedia, the free encyclopedia

The neutrality or factuality of this article or section may be compromised by unattributed statements. You can help Wikipedia by removing weasel worded statements.

Depigmentation of the skin is commonly linked to people who suffer with vitiligo who then apply a topical cream containing the organic compound monobenzone to remove the remaining pigment. The brand drug incorporating 20% monobenzone is Benoquin, made by ICN.

Increasingly, people who are not afflicted with the disease vitiligo have been experimenting with lower concentrations of self compounded mono creams in the hope of lightening their skin tone evenly.

An alternate method of lightening is to use the chemical mequinol over an extended period of time. Both monobenzone and mequinol produce dramatic whitening of the skin, but react very differently. For stubborn pigmented lesions the Q-switched ruby lazer, cryotherapy or TCA peels can be used to ensure the skin remains pigment free.

Mequinol leaves the skin looking extremely pale however, tanning is still possible. Monobenzone applied topically completely removes pigment in the long term and vigorous sun-safety needs to be adhered to for life.

People using monobenzone without previously having vitiligo do so because standard products containing hydroquinone or other lightening agents are not effective for their skin and due to price and active ingredient strength. However, monobenzone is not recommended for skin conditions other than vitiligo.

Although using such agents are controversial, the outcome most users report outweighs the risk.

Further information: Skin whitening